HALEOS LABS LIMITED
HALEOSLABS · Defence · NSE
₹1,388
Current Market Price
Fair Value (DCF)
₹2,070
Margin of Safety
+49.2%
Updated just now
YieldIQ Score
74/100
Piotroski F-Score
8/9
Economic Moat
Narrow
Confidence
56%
ROE
—
Debt/Equity
0.31
WACC
11.1%
Market Cap
₹420 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
14.0%
Return on capital employed
EV / EBITDA
11.0×
Enterprise multiple
Debt / EBITDA
1.9×
Leverage vs earnings
Interest Coverage
4.1×
EBIT covers interest
Current Ratio
1.06×
Short-term liquidity
Asset Turnover
0.86×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-1.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,387.9
Bear case
₹1,254.96
MoS -10.6%
Base case
₹2,070.42
MoS +33.0%
Bull case
₹2,752.3
MoS +49.6%
Ratio Trends
HALEOSLABS · last 8 annual periods
ROE
9.5%
ROCE
16.6%
Operating Margin
—
Debt / Equity
0.41×
PE
—
EV / EBITDA
—
Historical Financials
HALEOSLABS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹266 Cr | ₹350 Cr | ₹313 Cr | ₹300 Cr | ₹337 Cr | +6.1% |
| EBITDA | — | ₹48.4 Cr | ₹33.8 Cr | ₹34.7 Cr | ₹49.6 Cr | +0.6% |
| EBIT | ₹24.1 Cr | ₹38.9 Cr | ₹4.2 Cr | ₹9.9 Cr | — | -19.9% |
| PAT | ₹13.6 Cr | ₹25.3 Cr | ₹11.5 Cr | ₹6.5 Cr | ₹20.1 Cr | +10.4% |
| EPS (diluted) | ₹44.84 | ₹83.68 | ₹5.66 | ₹19.53 | — | -18.8% |
| CFO | ₹35.2 Cr | ₹-11.2 Cr | ₹14.7 Cr | ₹24.3 Cr | ₹34.1 Cr | -0.8% |
| CapEx | — | — | — | — | ₹-15.3 Cr | — |
| FCF | — | — | — | — | ₹18.7 Cr | +0.0% |
| Total Assets | — | ₹357 Cr | ₹395 Cr | ₹391 Cr | ₹390 Cr | +2.3% |
| Total Debt | — | — | ₹43.7 Cr | ₹64.6 Cr | ₹86.4 Cr | +18.6% |
| Shareholders' Equity | — | — | ₹169 Cr | ₹177 Cr | ₹212 Cr | +5.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
HALEOSLABS vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| LYKALABS LYKALABS | — | — | Pending | 7.7% | — |
| TAKE TAKE | — | — | Pending | — | — |
| BALAXI BALAXI | — | — | Pending | 10.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for HALEOSLABS in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HALEOS LABS LIMITED (HALEOSLABS.NS) trades at 1387.90 vs a model fair value of 2070.42, a gap of 49.2%. Piotroski F-score: 8/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HALEOSLABS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HALEOSLABS →
Compare
Head-to-head with peers
Compare HALEOSLABS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HALEOSLABSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.